Protalix BioTherapeutics, Inc. (AMEX:PLX) filed a Form 8-K with the Securities and Exchange Commission on February 11, 2026, disclosing a material event.
Protalix BioTherapeutics, Inc.'s stock currently trades at $2.92 with a market capitalization of $146.4M. The Healthcare company's stock moved following the disclosure.
